183 related articles for article (PubMed ID: 11134029)
1. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
Yu LC; Twu YC; Chang CY; Lin M
J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
[TBL] [Abstract][Full Text] [Related]
2. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles.
Lee S; Wu X; Son S; Naime D; Reid M; Okubo Y; Sistonen P; Redman C
Transfusion; 1996 Jun; 36(6):490-4. PubMed ID: 8669078
[TBL] [Abstract][Full Text] [Related]
3. Molecular defects underlying the Kell null phenotype.
Lee S; Russo DC; Reiner AP; Lee JH; Sy MY; Telen MJ; Judd WJ; Simon P; Rodrigues MJ; Chabert T; Poole J; Jovanovic-Srzentic S; Levene C; Yahalom V; Redman CM
J Biol Chem; 2001 Jul; 276(29):27281-9. PubMed ID: 11375401
[TBL] [Abstract][Full Text] [Related]
4. Three uncommon KEL alleles in one family with unusual Kell phenotypes explain a 35-year old conundrum.
Karamatic Crew V; Poole J; Burton N; Daniels G
Vox Sang; 2014 Apr; 106(3):242-7. PubMed ID: 24795954
[TBL] [Abstract][Full Text] [Related]
5. Organization of the gene encoding the human Kell blood group protein.
Lee S; Zambas E; Green ED; Redman C
Blood; 1995 Mar; 85(5):1364-70. PubMed ID: 7858266
[TBL] [Abstract][Full Text] [Related]
6. The KEL24 and KEL14 alleles of the Kell blood group system.
Lee S; Naime D; Reid M; Redman C
Transfusion; 1997 Oct; 37(10):1035-8. PubMed ID: 9354821
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the high-incidence antigens of the Kell blood group system.
Lee S; Naime DS; Reid ME; Redman CM
Transfusion; 1997; 37(11-12):1117-22. PubMed ID: 9426633
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for two novel null alleles of the KEL gene causes the Kell-null phenotype in a Japanese woman.
Koda Y; Soejima M; Tsuneoka M; Yasumoto K; Higashitani T; Sagawa K; Kimura H
Br J Haematol; 2002 Apr; 117(1):220-5. PubMed ID: 11918559
[TBL] [Abstract][Full Text] [Related]
9. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system.
Lee S; Reid ME; Redman CM
Vox Sang; 2001 Nov; 81(4):259-63. PubMed ID: 11904003
[TBL] [Abstract][Full Text] [Related]
11. KEL*02 alleles with alterations in and around exon 8 in individuals with apparent KEL:1,-2 phenotypes.
Wester ES; Steffensen R; Ligthart PC; Vad J; de Haas M; Storry JR; Olsson ML
Vox Sang; 2010 Aug; 99(2):150-7. PubMed ID: 20384970
[TBL] [Abstract][Full Text] [Related]
12. The Kell blood group system.
Redman CM; Lee S
Transfus Clin Biol; 1995; 2(4):243-9. PubMed ID: 8542022
[TBL] [Abstract][Full Text] [Related]
13. Point mutations causing the McLeod phenotype.
Russo DC; Lee S; Reid ME; Redman CM
Transfusion; 2002 Mar; 42(3):287-93. PubMed ID: 11961232
[TBL] [Abstract][Full Text] [Related]
14. [Different KEL gene mRNA transcripts in reticulocyte and non-reticulocyte cells].
Wang L; Yang Y; Wang C; Zhang J; Guo Z; Li Q; Chen H; Zhu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):520-6. PubMed ID: 18841563
[TBL] [Abstract][Full Text] [Related]
15. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
[TBL] [Abstract][Full Text] [Related]
16. The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function.
Lee S; Russo DC; Pu J; Ho M; Redman CM
Immunogenetics; 2000 Nov; 52(1-2):53-62. PubMed ID: 11132157
[TBL] [Abstract][Full Text] [Related]
17. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system.
Lee S; Wu X; Reid M; Redman C
Transfusion; 1995 Oct; 35(10):822-5. PubMed ID: 7570911
[TBL] [Abstract][Full Text] [Related]
19. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
